These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24846237)

  • 21. Endothelial microparticles in diseases.
    Chironi GN; Boulanger CM; Simon A; Dignat-George F; Freyssinet JM; Tedgui A
    Cell Tissue Res; 2009 Jan; 335(1):143-51. PubMed ID: 18989704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients.
    Chiva-Blanch G; Suades R; Padró T; Vilahur G; Peña E; Ybarra J; Pou JM; Badimon L
    Rev Esp Cardiol (Engl Ed); 2016 Jul; 69(7):672-80. PubMed ID: 27103451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolving role of microparticles in the pathophysiology of endothelial dysfunction.
    Lovren F; Verma S
    Clin Chem; 2013 Aug; 59(8):1166-74. PubMed ID: 23529703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In the View of Endothelial Microparticles: Novel Perspectives for Diagnostic and Pharmacological Management of Cardiovascular Risk during Diabetes Distress.
    Pernomian L; Moreira JD; Gomes MS
    J Diabetes Res; 2018; 2018():9685205. PubMed ID: 29862304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between circulating microparticles and hypertension and other cardiac disease biomarkers in the elderly.
    Usta Atmaca H; Akbas F; Aral H
    BMC Cardiovasc Disord; 2019 Jul; 19(1):164. PubMed ID: 31288734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obstructive sleep apnea syndrome, vascular pathology, endothelial function and endothelial cells and circulating microparticles.
    Stiefel P; Sánchez-Armengol MA; Villar J; Vallejo-Vaz A; Moreno-Luna R; Capote F
    Arch Med Res; 2013 Aug; 44(6):409-14. PubMed ID: 24051041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?
    Tushuizen ME; Diamant M; Sturk A; Nieuwland R
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):4-9. PubMed ID: 21160062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fructose and Uric Acid: Major Mediators of Cardiovascular Disease Risk Starting at Pediatric Age.
    Russo E; Leoncini G; Esposito P; Garibotto G; Pontremoli R; Viazzi F
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32599713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Importance of extracellular vesicles in hypertension.
    Liu ZZ; Jose PA; Yang J; Zeng C
    Exp Biol Med (Maywood); 2021 Feb; 246(3):342-353. PubMed ID: 33517775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microparticles: A Pivotal Nexus in Vascular Homeostasis and Disease.
    McGinn CM; MacDonnell BF; Shan CX; Wallace R; Cummins PM; Murphy RP
    Curr Clin Pharmacol; 2016; 11(1):28-42. PubMed ID: 26725878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria.
    Huang PH; Huang SS; Chen YH; Lin CP; Chiang KH; Chen JS; Tsai HY; Lin FY; Chen JW; Lin SJ
    J Hypertens; 2010 Aug; 28(8):1655-65. PubMed ID: 20520578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic syndrome and cardiovascular disease: Part I.
    Jiamsripong P; Mookadam M; Honda T; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(3):155-61. PubMed ID: 18607151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular vesicles in obesity and diabetes mellitus.
    Pardo F; Villalobos-Labra R; Sobrevia B; Toledo F; Sobrevia L
    Mol Aspects Med; 2018 Apr; 60():81-91. PubMed ID: 29175307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating endothelial progenitor cells, microparticles and vascular disease.
    Mehta JL; Szwedo J
    J Hypertens; 2010 Aug; 28(8):1611-3. PubMed ID: 20647855
    [No Abstract]   [Full Text] [Related]  

  • 35. Circulating microparticles as therapeutic targets in cardiovascular diseases.
    Azevedo LC; Pedro MA; Laurindo FR
    Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):41-51. PubMed ID: 18221102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial cell-derived microvesicles: potential mediators and biomarkers of pathologic processes.
    Vítková V; Živný J; Janota J
    Biomark Med; 2018 Feb; 12(2):161-175. PubMed ID: 29327597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial microparticles: sophisticated vesicles modulating vascular function.
    Curtis AM; Edelberg J; Jonas R; Rogers WT; Moore JS; Syed W; Mohler ER
    Vasc Med; 2013 Aug; 18(4):204-14. PubMed ID: 23892447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular vesicles in cardiovascular disease: are they Jedi or Sith?
    Osteikoetxea X; Németh A; Sódar BW; Vukman KV; Buzás EI
    J Physiol; 2016 Jun; 594(11):2881-94. PubMed ID: 26872404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and the endothelium.
    Quiñones MJ; Nicholas SB; Lyon CJ
    Curr Diab Rep; 2005 Aug; 5(4):246-53. PubMed ID: 16033673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial microparticles: Pathogenic or passive players in endothelial dysfunction in autoimmune rheumatic diseases?
    McCarthy EM; Wilkinson FL; Parker B; Alexander MY
    Vascul Pharmacol; 2016 Nov; 86():71-76. PubMed ID: 27291140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.